UTMD
What one share of Utah Medical Products holds
Surgical and Medical Instruments and Apparatus
Utah Medical Products, Inc. (“UTMD” or “the Company”) is in the business of producing high quality cost-effective medical devices that are predominantly differentiated by safety and improved patient outcomes.
Utah Medical Products’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $11.31 |
|---|---|
| Profit | $3.28 |
| Capex (buildings and equipment) | $0.13 |
| Free cash flow | $3.58 |
| Dividends | $1.23 |
| Cash and investments | $27.50 |
| Debt | $0.06 |
| Book value | $38.34 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $10.43 | $3.22 | $0.87 | $2.98 | — | $18.65 |
| 2017 | $11.08 | $2.28 | $0.43 | $4.10 | — | $20.99 |
| 2018 | $11.21 | $4.95 | $0.11 | $4.38 | — | $23.92 |
| 2019 | $12.54 | $3.94 | $0.14 | $4.42 | — | $27.16 |
| 2020 | $11.49 | $2.94 | $0.23 | $5.25 | — | $28.22 |
| 2021 | $13.40 | $4.04 | $0.15 | $5.64 | — | $29.31 |
| 2022 | $14.35 | $4.52 | $0.22 | $5.58 | — | $31.49 |
| 2023 | $13.81 | $4.57 | $0.18 | $5.95 | — | $35.35 |
| 2024 | $11.68 | $3.96 | $0.07 | $4.17 | — | $35.21 |
| 2025 | $11.89 | $3.48 | $0.11 | $4.42 | — | $37.44 |